Seoul, South Korea

Hwangseo Park

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bioneer Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hwangseo Park. Retrieved from https://idiyas.com/inventor/hwangseo-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Hwangseo Park

Introduction: Hwangseo Park, a prominent inventor based in Seoul, South Korea, is recognized for his significant contributions to the field of molecular biology. With a sole patent to his name, Park's work demonstrates a commitment to advancing scientific knowledge and application in RNA storage and preservation.

Latest Patents: Hwangseo Park holds a patent titled "Compound for inhibiting activity of ribonuclease, and container for storing nucleic acid containing the same." This innovative patent introduces an RNase activity inhibitory compound designed to effectively control the activity of ribonuclease, which promotes the degradation of extracted RNAs. Moreover, the invention includes a sample storage container that utilizes this compound, proving essential for the storage of RNAs during extraction processes or for previously extracted RNAs.

Career Highlights: Hwangseo Park works at Bioneer Corporation, a leading biotechnology company that specializes in molecular biology research and development. His expertise and focus on RNA stability have positioned him as a key player in the scientific community, further enhancing the capabilities of the research conducted at Bioneer.

Collaborations: Throughout his career, Park has collaborated with talented individuals in the field. Notable colleagues include Jong Hoon Kim and Han Oh Park, both of whom contribute to multidisciplinary projects aimed at fostering groundbreaking innovations in biotechnology.

Conclusion: Hwangseo Park exemplifies the spirit of innovation within the field of molecular biology. His patent on the RNase activity inhibitory compound not only showcases his ingenuity but also reflects the importance of collaboration and teamwork in advancing scientific research. As he continues to work at Bioneer Corporation, the impact of his inventions will likely resonate within the scientific community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…